-
Top Wall Street Stories: Advaxis (NASDAQ:ADXS), Cellectar Biosciences (NASDAQ:CLRB), ITT Educational Services Inc. (NYSE:ESI), JD.com (NASDAQ:JD), KKR & Co. (NYSE:KKR)
On Friday shares of Advaxis, Inc. (NASDAQ:ADXS) closed at $20.08. Janney Montgomery Scott started coverage on shares of Advaxis (NASDAQ:ADXS) in a research note released on Thursday morning, TheFlyOnTheWall.com reports. The firm issued a buy rating on the stock. Cellectar Biosciences, Inc. (NASDAQ:CLRB) in last trading activity advanced 3.01% to close at $2.74. Company weekly…
-
Investors Alert: The Procter & Gamble Company (NYSE:PG), Advaxis (NASDAQ:ADXS), Tile Shop (NASDAQ:TTS), Discover Financial Services (NYSE:DFS), Coast Distribution System (NYSEMKT:CRV)
On Wednesday shares of The Procter & Gamble Company (NYSE:PG) closed at $79.70. Company’s sales growth for last 5 years was 1.60% and EPS growth for next 5 years is recorded as 6.73%. The Procter & Gamble Company (NYSE:PG) was downgraded by Societe Generale from a “buy” rating to a “hold” rating in a research…
-
Active Watch List: Advaxis (NASDAQ:ADXS), CytRx Corporation (NASDAQ:CYTR), General Electric Company (NYSE:GE), Ply Gem Holdings, Inc (NYSE:PGEM), Vical Incorporated (NASDAQ:VICL)
On Friday shares of Advaxis, Inc. (NASDAQ:ADXS) closed at $17.07. Advaxis, Inc. (NASDAQ:ADXS) on April 30, 2015, reported the pricing of its previously announced underwritten public offering of 2,800,000 shares of its common stock at a public offering price of $19.00 per share. Advaxis has also granted the underwriters a 30-day option to purchase up…
-
Top Wall Street Stories: Advaxis (NASDAQ:ADXS), Pandora Media Inc (NYSE:P), Mylan N.V. (NASDAQ:MYL), Intersil Corporation (NASDAQ:ISIL), Kronos Worldwide (NYSE:KRO)
On Monday shares of Advaxis, Inc. (NASDAQ:ADXS) closed at $21.28. On April 21, Advaxis, Inc. (NASDAQ:ADXS) announced the data of one clinical and two preclinical studies highlighting the survival outcomes and anti-tumor effects of its proprietary Lm-LLO cancer immunotherapy technology at the American Association for Cancer Research (AACR) Annual Meeting 2015, held April 18 –…
-
Active Stocks to Watch: Advaxis (NASDAQ:ADXS), Petrobras Argentina SA (NYSE:PZE), STAAR Surgical Company (NASDAQ:STAA), Rogers Communications (NYSE:RCI), MGM Resorts International (NYSE:MGM)
On Monday shares of Advaxis, Inc. (NASDAQ:ADXS) closed at $21.28. Advaxis, Inc. (NASDAQ:ADXS) on April 21, 2015, declared the data of one clinical and two preclinical studies highlighting the survival outcomes and anti-tumor effects of its proprietary Lm-LLO cancer immunotherapy technology at the American Association for Cancer Research (AACR) Annual Meeting 2015, held April 18…
-
Morning Alert: Reliv International (NASDAQ:RELV), Advaxis (NASDAQ:ADXS), Calgon Carbon Corporation (NYSE:CCC), Ericsson (NASDAQ:ERIC), Encana Corporation (NYSE:ECA)
On Thursday shares of Reliv International, Inc. (NASDAQ:RELV) closed at $1.18. Company’s sales growth for last 5 years was -7.70% and EPS growth for next 5 years is recorded as 20.40%. Reliv International, Inc. (NASDAQ:RELV) on 14 April, announced that the company has installed a new state-of-the-art encapsulation line at Reliv headquarters to manufacture LunaRich…
-
Active Watch List: Cisco Systems (NASDAQ:CSCO), Advaxis (NASDAQ:ADXS), Cepheid (NASDAQ:CPHD), Evoke Pharma (NASDAQ:EVOK), Oracle Corporation (NYSE:ORCL)
Cisco Systems, Inc. (NASDAQ:CSCO) shares moved up 1.58% in last trading session and ended the day at $28.25. CSCO Gross Margin is 60.00% and its return on assets is 8.30%. Cisco Systems, Inc. (NASDAQ:CSCO) quarterly performance is 1.29%. On 10 April, Cisco Systems, Inc. (NASDAQ:CSCO) and service provider Level 3 have teamed up take down…
-
Big Movers: Ally Financial Inc. (NYSE:ALLY), Advaxis (NASDAQ:ADXS), Smith Micro Software Inc. (NASDAQ:SMSI), Chico’s FAS Inc. (NYSE:CHS), Alcoa Inc. (NYSE:AA)
On Tuesday shares of Ally Financial Inc. (NYSE:ALLY) closed at $20.86. Company’s sales growth for last 5 years was -8.10% and EPS growth for next 5 years is recorded as 16.43%. Credit Suisse Group AG reissued their neutral rating on shares of Ally Financial Inc. (NYSE:ALLY) in a research report released on Tuesday morning. Advaxis,…
-
Active Stocks: Advaxis (NASDAQ:ADXS), Remark Media (NASDAQ:MARK), The Cato Corporation (NYSE:CATO), The Buckle (NYSE:BKE), Fred’s (NASDAQ:FRED)
On Wednesday shares of Advaxis, Inc. (NASDAQ:ADXS) closed at $18.10. Advaxis Inc. (NASDAQ:ADXS) and Merck & Co. Inc. announced that enrollment has initiated in the Phase 1/2 clinical trial evaluating the combination of ADXS-PSA (ADXS31-142), an investigational Lm-LLO immunotherapy, and KEYTRUDA (pembrolizumab), the first anti-PD-1 (programmed death receptor-1) therapy approved in the United States, in…
-
News Buzz: Advaxis (NASDAQ:ADXS), Synthetic Biologics Inc. (NYSEMKT:SYN), KLA-Tencor Corporation (NASDAQ:KLAC), The ExOne Company (NASDAQ:XON), Novavax (NASDAQ:NVAX)
On Tuesday shares of Advaxis, Inc. (NASDAQ:ADXS) closed at $15.39. On 6 April, Advaxis, Inc. (NASDAQ:ADXS) announced that it is entering into a clinical trial collaboration agreement with the Radiation Therapy Oncology Group (RTOG) Foundation to evaluate the safety and efficacy of Advaxis’s lead cancer immunotherapy, ADXS-HPV (ADXS11-001), in a pivotal Phase 2/3 anal cancer…